TOFA-PREDICT study protocol: a stratification trial to determine key immunological factors predicting tofacitinib efficacy and drug-free remission in psoriatic arthritis (PsA)

TOFA-PREDICT study protocol: a stratification trial to determine key immunological factors predicting tofacitinib efficacy and drug-free remission in psoriatic arthritis (PsA)

Introduction Psoriatic arthritis (PsA) is a chronic, inflammatory, musculoskeletal disease that affects up to 30% of patients with psoriasis. Current challenges in clinical care and research include personalised treatment, understanding the divergence of therapy response and unravelling the multifac...

Full description

Bibliographic Details
Main Authors: Paco M J Welsing, Floris P J G Lafeber, Pim A de Jong, Janneke Tekstra, Marloes W Heijstek, Julia Spierings, Nienke J Kleinrensink, Wouter Foppen, Emmerik F A Leijten, Sarita A Y Hartgring, Mylène P Jansen, Juliëtte N Pouw, Frank T Perton, Nanette L A Vincken, Saeed Arbabi
Format: Article
Language:English
Published: BMJ Publishing Group 2022-10-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/10/e064338.full

Internet

https://bmjopen.bmj.com/content/12/10/e064338.full

Similar Items